The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Loss of IFN-γ Production by Invariant NK T Cells in Advanced Cancer
Abstract
Invariant NK T cells express certain NK cell receptors and an invariant TCRα chain specific for the MHC class I-like CD1d protein. These invariant NK T cells can regulate diverse immune responses in mice, including antitumor responses, through mechanisms including rapid production of IL-4 and IFN-γ, but their physiological functions remain uncertain. Invariant NK T cells were markedly decreased in peripheral blood from advanced prostate cancer patients, and their ex vivo expansion with a CD1d-presented lipid Ag (α-galactosylceramide) was diminished compared with healthy donors. Invariant NK T cells from healthy donors produced high levels of both IFN-γ and IL-4. In contrast, whereas invariant NK T cells from prostate cancer patients also produced IL-4, they had diminished IFN-γ production and a striking decrease in their IFN-γ:IL-4 ratio. The IFN-γ deficit was specific to the invariant NK T cells, as bulk T cells from prostate cancer patients produced normal levels of IFN-γ and IL-4. These findings support an immunoregulatory function for invariant NK T cells in humans mediated by differential production of Th1 vs Th2 cytokines. They further indicate that antitumor responses may be suppressed by the marked Th2 bias of invariant NK T cells in advanced cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997) · Science · doi:10.1126/science.278.5343.1626 · Cited by 2,400
Self-citationMOUSE CD1-SPECIFIC NK1 T CELLS: Development, Specificity, and Function
Bendelac, A., Rivera, M. N., Park, S.-H., & Roark, J. H. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.535 · Cited by 1,326
Requirement for V α 14 NKT Cells in IL-12-Mediated Rejection of Tumors
Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, H., Kanno, M., & Taniguchi, M. (1997) · Science · doi:10.1126/science.278.5343.1623 · Cited by 1,237
CD1 Recognition by Mouse NK1 + T Lymphocytes
Bendelac, A., Lantz, O., Quimby, M. E., Yewdell, J. W., Bennink, J. R., & Brutkiewicz, R. R. (1995) · Science · doi:10.1126/science.7538697 · Cited by 914
Carnaud, C., Lee, D., Donnars, O., Park, S.-H., Beavis, A., Koezuka, Y., & Bendelac, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.4647 · Cited by 854
Self-citationDifferential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
Smyth, M. J., Thia, K. Y. T., Street, S. E. A., Cretney, E., Trapani, J. A., Taniguchi, M., Kawano, T., Pelikan, S. B., Crowe, N. Y., & Godfrey, D. I. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.4.661 · Cited by 829
Porcelli, S., Yockey, C. E., Brenner, M. B., & Balk, S. P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.1.1 · Cited by 756
Self-citationNKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway
Terabe, M., Matsui, S., Noben-Trauth, N., Chen, H., Watson, C., Donaldson, D. D., Carbone, D. P., Paul, W. E., & Berzofsky, J. A. (2000) · Nature Immunology · doi:10.1038/82771 · Cited by 699
Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
Wilson, S. B., Kent, S. C., Patton, K. T., Orban, T., Jackson, R. A., Exley, M., Porcelli, S., Schatz, D. A., Atkinson, M. A., Balk, S. P., et al. (1998) · Nature · doi:10.1038/34419 · Cited by 646
Self-citationBrossay, L., Chioda, M., Burdin, N., Koezuka, Y., Casorati, G., Dellabona, P., & Kronenberg, M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1521 · Cited by 642
Self-citationKitamura, H., Iwakabe, K., Yahata, T., Nishimura, S.-I., Ohta, A., Ohmi, Y., Sato, M., Takeda, K., Okumura, K., Van Kaer, L., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1121 · Cited by 626
CD1d1 Mutant Mice Are Deficient in Natural T Cells That PromptlyProduce IL-4
Mendiratta, S. K., Martin, W. D., Hong, S., Boesteanu, A., Joyce, S., & Van Kaer, L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80290-3 · Cited by 595
Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells
Exley, M., Garcia, J., Balk, S. P., & Porcelli, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.109 · Cited by 531
Self-citationRole of NK1.1 + T Cells in a T H 2 Response and in Immunoglobulin E Production
Yoshimoto, T., Bendelac, A., Watson, C., Hu-Li, J., & Paul, W. E. (1995) · Science · doi:10.1126/science.270.5243.1845 · Cited by 496
Immunoglobulin E Production in the Absence of Interleukin-4-Secreting CD1-Dependent Cells
Smiley, S. T., Kaplan, M. H., & Grusby, M. J. (1997) · Science · doi:10.1126/science.275.5302.977 · Cited by 489
Impaired NK1+ T Cell Development and Early IL-4 Production in CD1-Deficient Mice
Chen, Y.-H., Chiu, N. M., Mandal, M., Wang, N., & Wang, C.-R. (1997) · Immunity · doi:10.1016/s1074-7613(00)80289-7 · Cited by 486
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Sato, H., Kondo, E., Harada, M., Koseki, H., Nakayama, T., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5690 · Cited by 476
Self-citationDellabona, P., Padovan, E., Casorati, G., Brockhaus, M., & Lanzavecchia, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1171 · Cited by 454
Singh, N., Hong, S., Scherer, D. C., Serizawa, I., Burdin, N., Kronenberg, M., Koezuka, Y., & Kaer, L. V. (1999) · PubMed · Cited by 358
Self-citationEarly quantitative and functional deficiency of NK1+‐like thymocytes in the NOD mouse
Gombert, J., Herbelin, A., Tancrède‐Bohin, E., Dy, M., Carnaud, C., & Bach, J. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261226 · Cited by 358
Sonoda, K.-H., Exley, M., Snapper, S., Balk, S. P., & Stein-Streilein, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.9.1215 · Cited by 354
Self-citationImmune suppression and skin cancer development: regulation by NKT cells
Moodycliffe, A. M., Nghiem, D., Clydesdale, G., & Ullrich, S. E. (2000) · Nature Immunology · doi:10.1038/82782 · Cited by 320
Singh, N., Hong, S., Scherer, D. C., Serizawa, I., Burdin, N., Kronenberg, M., Koezuka, Y., & Van Kaer, L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2373 · Cited by 311
Self-citationSumida, T., Sakamoto, A., Murata, H., Makino, Y., Takahashi, H., Yoshida, S., Nishioka, K., Iwamoto, I., & Taniguchi, M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.4.1163 · Cited by 303
The Anti-Tumor Activity of IL-12: Mechanisms of Innate Immunity That Are Model and Dose Dependent
Smyth, M. J., Taniguchi, M., & Street, S. E. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2665 · Cited by 301
Burdin, N., Brossay, L., & Kronenberg, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199906)29:06<2014::aid-immu2014>3.0.co;2-g · Cited by 301
Management of Cancer of the Prostate
Wood, A. J. J., & Catalona, W. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410133311507 · Cited by 294
Mieza, M. A., Itoh, T., Cui, J. Q., Makino, Y., Kawano, T., Tsuchida, K., Koike, T., Shirai, T., Yagita, H., Matsuzawa, A., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.4035 · Cited by 286
Gollob, J., Mier, J. W., Veenstra, K. G., McDermott, D. F., Clancy, D., Clancy, M., & Atkins, M. B. (2000) · PubMed · Cited by 285
α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria
Gonzalez-Aseguinolaza, G., de Oliveira, C., Tomaska, M., Hong, S., Bruna-Romero, O., Nakayama, T., Taniguchi, M., Bendelac, A., Van Kaer, L., Koezuka, Y., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.15.8461 · Cited by 262
Self-citationToura, I., Kawano, T., Akutsu, Y., et al. (1999) · PubMed · Cited by 260
Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells.
Kawano, T., Nakayama, T., Kamada, N., Kaneko, Y., Harada, M., Ogura, N., Akutsu, Y., Motohashi, S., Iizasa, T., Endo, H., et al. (1999) · PubMed · Cited by 258
Association Between αβTCR+CD4−CD8− T-Cell Deficiency and IDDM in NOD/Lt Mice
Baxter, A. G., Kinder, S. J., Hammond, K. J. L., Scollay, R., & Godfrey, D. I. (1997) · Diabetes · doi:10.2337/diab.46.4.572 · Cited by 257
Tumor-induced immune dysfunction
Kiessling, R., Wasserman, K., Horiguchi, S., Kono, K., Sjöberg, J., Pisa, P., & Petersson, M. (1999) · Cancer Immunology, Immunotherapy · doi:10.1007/s002620050586 · Cited by 237
Toura, I., Kawano, T., Akutsu, Y., Nakayama, T., Ochiai, T., & Taniguchi, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2387 · Cited by 235
Tomura, M., Yu, W., Ahn, H., Yamashita, M., Yang, Y., Ono, S., Hamaoka, T., Kawano, T., Taniguchi, M., Koezuka, Y., et al. (1999) · PubMed · Cited by 209
Self-citationCD1d structure and regulation on human thymocytes, peripheral blood T cells,B cells and monocytes
Exley, M., Garcia, J., Wilson, S. B., Spada, F., Gerdes, D., Tahir, S. M. A., Patton, K. T., Blumberg¶, R. S., Porcelli, S., Chott**, A., et al. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00001.x · Cited by 196
Self-citationApostolou, I., Takahama, Y., Belmant, C., Kawano, T., Huerre, M., Marchal, G., Cui, J., Taniguchi, M., Nakauchi, H., Fournié, J.-J., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5141 · Cited by 196
Exley, M., Porcelli, S., Furman, M., Garcia, J., & Balk, S. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.867 · Cited by 194
Self-citationTomura, M., Yu, W.-G., Ahn, H.-J., Yamashita, M., Yang, Y.-F., Ono, S., Hamaoka, T., Kawano, T., Taniguchi, M., Koezuka, Y., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.93 · Cited by 173
Self-citationPrussin, C., & Foster, B. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.12.5862 · Cited by 153
CD4+ Vα14 natural killer T cells are essential for acceptance of rat islet xenografts in mice
Ikehara, Y., Yasunami, Y., Kodama, S., Takanobu, M. A. K. I., Nakano, M., Nakayama, T., Taniguchi, M., & Ikeda, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8922 · Cited by 150
Denkers, E., Scharton‐Kersten, T., Barbieri, S., Caspar, P., & Sher, A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.1.131 · Cited by 148
TREATMENT OF METASTATIC PROSTATE CANCER
Bubley, G. J., & Balk, S. P. (1996) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70363-4 · Cited by 19
Self-citation
Cited by
Bendelac, A., Savage, P. B., & Teyton, L. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141711 · Cited by 2,155
CD1: Antigen Presentation and T Cell Function
Brigl, M., & Brenner, M. B. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104608 · Cited by 1,035
TOWARD AN UNDERSTANDING OF NKT CELL BIOLOGY: Progress and Paradoxes
Kronenberg, M. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115742 · Cited by 1,029
Going both ways: Immune regulation via CD1d-dependent NKT cells
Godfrey, D. I., & Kronenberg, M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423594 · Cited by 877
Natural killer cells in cancer biology and therapy
Wu, S.-Y., Fu, T., Jiang, Y.-Z., & Shao, Z.-M. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01238-x · Cited by 863
Metadata
- Authors
- Muhammad Ali Tahir, S., Cheng, O., Shaulov, A., Koezuka, Y., Bubley, G. J., Wilson, S. B., Balk, S. P., & Exley, M. A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-10-01
- Volume
- 167
- Issue
- 7
- Pages
- 4046-4050
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1678468169
- Cited by
- 386
- References
- 44
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.